BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19503739)

  • 1. HPV infection and p53 inactivation in pterygium.
    Tsai YY; Chang CC; Chiang CC; Yeh KT; Chen PL; Chang CH; Chou MC; Lee H; Cheng YW
    Mol Vis; 2009 Jun; 15():1092-7. PubMed ID: 19503739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
    Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
    Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.
    Chen TH; Huang CC; Yeh KT; Chang SH; Chang SW; Sung WW; Cheng YW; Lee H
    World J Gastroenterol; 2012 Aug; 18(30):4051-8. PubMed ID: 22912557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.
    Cheng YW; Wu MF; Wang J; Yeh KT; Goan YG; Chiou HL; Chen CY; Lee H
    Cancer Res; 2007 Nov; 67(22):10686-93. PubMed ID: 18006810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting human papillomavirus in ocular surface diseases.
    Woods M; Chow S; Heng B; Glenn W; Whitaker N; Waring D; Iwasenko J; Rawlinson W; Coroneo MT; Wakefield D; Di Girolamo N
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8069-78. PubMed ID: 24255045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18.
    Isayeva T; Said-Al-Naief N; Ren Z; Li R; Gnepp D; Brandwein-Gensler M
    Head Neck Pathol; 2013 Jun; 7(2):135-48. PubMed ID: 23233027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.
    Bonetta AC; Mailly L; Robinet E; Travé G; Masson M; Deryckere F
    Biochem Biophys Res Commun; 2015 Oct; 465(4):658-64. PubMed ID: 26241675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
    Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
    Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
    Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
    Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.